Fig. 3From: CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutationReverse hybridization of a thalassemia patient before and after editing using CRISPR. a Reverse hybridization of unedited cells. IVS-1-110 mutation is shown. b Reverse hybridization of CRISPR/Cas9-edited cells. The IVS-1-110 mutation disappeared and the wild-type sequence was regainedBack to article page